United States · FDA National Drug Code directory

Gemfibrozil

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
63187-772_e7d02874-58bd-44fb-afdf-41b8f82a93e3
Product NDC
63187-772
Form
TABLET
Composition / generic term
Gemfibrozil
Labeler
Proficient Rx LP
Marketing category
ANDA
Marketing start / end (source format)
20160708
Source listing expiry
20261231

Source-listed ingredients

  • GEMFIBROZIL — 600 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET in 1 BOTTLE (63187-772-30) · 63187-772-30
  • 60 TABLET in 1 BOTTLE (63187-772-60) · 63187-772-60
  • 120 TABLET in 1 BOTTLE (63187-772-72) · 63187-772-72
  • 180 TABLET in 1 BOTTLE (63187-772-78) · 63187-772-78
  • 90 TABLET in 1 BOTTLE (63187-772-90) · 63187-772-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →